Signal active
Bio
Noam Soloman is the CEO and co-founder at Immunai, the first and only company to map the entire immune system for better detection, diagnosis, and treatment of disease. Leveraging single-cell technologies and machine learning algorithms, Immunai has mapped out thousands of immune cells and their functions, building the largest proprietary data set in the world for clinical immunological data. Prior to co-founding Immunai, Noam had a dual career in both the industry and academia. Noam is a double Ph.D., and served as a post-doctoral researcher in the Mathematics department at MIT, and in the center of mathematical sciences and applications at Harvard University. In his research, he developed and applied tools from algebra and Algebraic Geometry in the study of classical problems in combinatorics. Noam also worked as an algorithms developer in the Israeli defense forces and subsequently as a data scientist, consultant and head of data science in several hi-tech companies in Israel.
Location
Tel Aviv-yafo, Tel Aviv, Israel, Asia
Social
Primary Organization
2018
101-250
Biotechnology, Artificial Intelligence (AI), Machine Learning, Analytics, Therapeutics
Jobs history
1
Immunai
CEO and co-founder
2019 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Noam Solomon is the CEO and co-founder at Immunai, based in Asia. With a background in Biotechnology, Noam Solomon has a rich history of leadership and innovation. Noam Solomon studied PhD Computer Science @ Tel Aviv University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
1
0
Personal investment
1
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Oct 28, 2021 | NeuraLight | Seed Round - NeuraLight | 5.5M |
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.